Ilseong Pioglitazone Hydrochloride Tablet 30 mg
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.
MFDS item code 202003901 · Approved 2020.05.27
This product's status changed to Expired on 2025.05.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help control blood sugar in patients with type 2 diabetes. It can be administered as monotherapy, and if ineffective after using other oral hypoglycemic agents, it may be combined with sulfonylureas, metformin, and insulin. Additionally, for patients with type 2 diabetes, it is crucial to also pursue nutritional counseling, weight loss, and exercise therapy. These treatment methods not only assist in initial treatment but also help maintain the long-term efficacy of the medication. Therefore, this medication is utilized to effectively improve blood sugar levels.
This medicine is administered orally once daily, regardless of meals. As monotherapy, treatment may be initiated at 15 mg once daily and, if the effect is inadequate, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily with a sulfonylurea, metformin, or insulin. The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use.
This medication is used for the treatment of type 2 diabetes and is effective in reducing blood sugar levels by improving insulin resistance. During the use of this medication, attention should be paid to symptoms of heart failure. If sudden weight gain, shortness of breath, or swelling in the legs occurs, it is imperative to consult a doctor immediately. Patients with heart failure or a history of heart failure should not use this medication. Patients with active bladder cancer or a history of bladder cancer should also avoid this medication, and if symptoms such as urination disorders or hematuria arise, they should promptly inform medical staff. Patients with severely impaired liver or kidney function, diabetic ketoacidosis patients, and type 1 diabetes patients should not use this medication either. When used in combination with other hypoglycemic agents or insulin, there is a risk of hypoglycemia, so one must be well aware of the symptoms of hypoglycemia and how to respond, adjusting doses of other medications if necessary. Edema or weight gain may occur, so it is important to regularly monitor for these symptoms. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and pre-menopausal women should use adequate contraception as this medication may trigger ovulation. Elderly patients should be monitored closely for cardiovascular and kidney functions during use. Regular liver function tests and blood sugar monitoring should be conducted, and if symptoms indicating potential liver damage arise, medical staff should be informed immediately. In cases of overdose, even if there are no specific symptoms, one should go to a hospital immediately for appropriate treatment. This medication is not used in children due to unknown safety and efficacy.
Congestive heart failure, excessive and rapid weight change, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular risk factors, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, edema, liver failure, diabetic macular edema with decreased vision, elevated serum ALT levels, elevated serum creatine kinase, bladder cancer, decreased hemoglobin, increased plasma volume, hepatotoxicity, fractures, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest discomfort, tremors, chills, gastrointestinal disorders, epigastric discomfort, numbness, muscle rigidity, head discomfort, elevated liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart failure
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a container that blocks light and air, and storing it in a location with low humidity is important. The appropriate storage temperature is between 15°C and 30°C, and it is recommended to maintain a temperature around 25°C.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Ilseong IS Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.